INSIGHTS ON DRUG DEVELOPMENT

• Easy Automation For Cell-Based Assays

  Automated GPCR screening is now faster and more scalable with integrated cell-based assay solutions. Discover how combining high-throughput platforms with flexible assay kits can streamline workflows.

• Leveraging Optimized Transient Expression For Material Generation And Early Stage Insight

  By using an optimized transient transfection platform, drug developers can accelerate their characterization and early development activities, facilitating continuity for a drug's scale-up.

• Techniques For PEGylation Site Identification

  Examine how our innovative methods enable the precise identification of PEGylation sites, unlocking deeper insights into the structure, stability, and function of biotherapeutics.

• Neoantigen-Based Personalized Cancer Vaccine

  Personalized cancer vaccines are advancing quickly, but effective delivery remains a major hurdle. Learn how mRNA and lipid nanoparticle design influence targeting, endosomal escape, and repeat dosing.

• Advancing Cell Therapies With Lipid Nanoparticles

  3/24/2025

  Cell therapies, using reprogrammed immune cells, offer innovative treatments for diseases. Discover how lipid nanoparticles (LNPs) enhance these therapies by delivering RNA for gene modulation and next-gen treatments.

• Silyl Ether Linkers For Hydroxyl-Bearing Payload Conjugates

  6/19/2026

  Discover an innovative approach to drug conjugation that expands the range of molecules suitable for targeted therapies while preserving their biological activity and enabling controlled drug release.

• Epigenetics Application Guide

  10/2/2024

  To fully understand biology and disease mechanisms, it is crucial to explore the role of epigenetic factors. Explore how epigenetic regulation works and methods to study these essential components.

• Asymchem's Green Commitment

  3/11/2026

  See how advanced reaction technologies — flow chemistry, photochemistry, and biocatalysis — boost efficiency, improve safety, and cut environmental impact, enabling more sustainable development practices.

• NGS Identification Of Internal Tandem Duplications In FLT3

  6/15/2026

  Accurately identifying genetic duplications in leukemia requires more than conventional sequencing. See how advanced enrichment and analysis approaches enable deeper insight into variant structure.